Boothbay Fund Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-64,258
| Closed | -$3.05M | – | 1933 |
|
|
2025
Q3 | $3.05M | Buy |
64,258
+692
| +1% | +$33.5K | 0.08% | 449 |
|
|
2025
Q2 | $3.39M | Sell |
63,566
-9,100
| -13% | -$414K | 0.1% | 383 |
|
|
2025
Q1 | $2.94M | Buy |
+72,666
| New | +$3.08M | 0.1% | 343 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1465 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1589 |
|
|
2023
Q4 | – | Sell |
-40,280
| Closed | -$2.04M | – | 1630 |
|
|
2023
Q3 | $2.04M | Buy |
+40,280
| New | +$1.88M | 0.06% | 484 |
|
|
2023
Q2 | – | Sell |
-10,035
| Closed | -$384K | – | 1764 |
|
|
2023
Q1 | $384K | Buy |
+10,035
| New | +$447K | 0.01% | 1382 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1973 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2209 |
|
|
2020
Q1 | – | Sell |
-10,000
| Closed | -$222K | – | 834 |
|
|
2019
Q4 | $222K | Buy |
+10,000
| New | +$207K | 0.02% | 681 |
|
